Although hepatocyte growth factor (HGF) can act synergistically or antagonistically with transforming growth factor-b (TGF-b) signaling, molecular mechanism of their crosstalk remains unknown. Using antibodies which selectively distinguished receptor-regulated Smads (R-Smads) phosphorylated at linker regions from those at C-terminal regions, we herein showed that either HGF or TGF-b treatment of normal stomach-origin cells activated the JNK pathway, thereafter inducing endogenous R-Smads phosphorylation at linker regions. However, the phosphorylation at their C-terminal regions was not induced by HGF treatment. The activated JNK could directly phosphorylate R-Smads in vitro at the same sites that were phosphorylated in response to TGF-b or HGF in vivo. Thus, the linker regions of R-Smads were the common phosphorylation sites for HGF and TGF-b signaling pathways. The phosphorylation induced by simultaneous treatment with HGF and TGF-b allowed R-Smads to associate with Smad4 and to translocate into the nucleus. JNK pathway involved HGF and TGF-bmediated infiltration potency since a JNK inhibitor SP600125 caused the reduction of invasive capacity induced by HGF and TGF-b signals. Moreover, a combined treatment with HGF and TGF-b led to a potent increase in plasminogen activator inhibitor type 1 transcriptional activity through Smad3 phosphorylation at the linker region. In contrast, HGF treatment reduced TGF-bdependent activation of p15 INK4B promoter, in which Smad3 phosphorylation at the C-terminal region was involved. In conclusion, HGF and TGF-b transmit the signals through JNK-mediated R-Smads phosphorylation at linker regions.
Introduction
Transforming growth factor-b (TGF-b) belongs to a family of multifunctional cytokines that participates not only in tumor suppressor activities such as growth inhibition, but also in oncogenic activities such as growth stimulation, increased motility and invasiveness (Roberts and Sporn, 1990) .
Recent studies have elucidated how TGF-b initiates its response (Massague´, 1998) . TGF-b binds to and activates two different transmembrane receptor serine/ threonine kinases. Receptor-activated Smads (R-Smads) such as Smad2 and Smad3 are phosphorylated by the activated TGF-b type I receptor (TbRI) on the Cterminal SSXS motif (Macı´as-Silva et al., 1996) . The activated R-Smads form the complex with the common partner Smad4, and are translocated into the nucleus . The heteromeric Smad complex interacts with other transcription factors at regulatory promoter sequences of target genes , and recruits coactivators or corepressors to regulate the transcription of the specific genes, positively or negatively (Wrana, 2000a) . R-Smads and Smad4 contain two highly conserved domains, the Mad homology (MH) 1 domains and the MH2 domains, which are connected by middle linker regions (Massague´, 1998) . Whereas their MH1 domains can interact with the DNA, the MH2 domains are endowed with transcriptional activation properties. In addition to these Smads, Smad7 induced by TGF-b blocks the phosphorylation of R-Smads by acting as a pseudosubstrate for TbRI (Nakao et al., 1997) .
In contrast to TGF-b family ligands, hepatocyte growth factor (HGF) and epidermal growth factor (EGF) signal their responses through transmembrane receptor tyrosine kinases (Schlessinger, 2002) . Multiple signaling pathways that originate from these receptors have been identified. The most prominent pathways are mediated by mitogen-activated protein kinases (MAPKs); extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase/stress-activated protein kinase-1 (JNK/SAPK1), and stress-activated protein kinase-2 (p38), which in turn activate several transcription factors (Robinson and Cobb, 1997) . Notably, TGF-b also induces activation of the MAPK pathways through upstream mediators Ras, RhoA, and TGF-bactivated kinase 1 (TAK1) (Yamaguchi et al., 1995) .
TGF-b was originally identified for its ability to transform normal rat kidney (NRK) fibroblasts in vitro, and this effect was required for the presence of EGF (Roberts et al., 1981) . FGF and TGF-b synergistically induce mesoderm in vertebrate development (Kimelman and Kirschner, 1987) . Collectively, TGF-b can act synergistically with ligands signaling via receptor tyrosine kinases. Recent reports regarding R-Smads phosphorylation at linker regions upon HGF or EGF treatment (Kretzschmar et al., 1997 (Kretzschmar et al., , 1999 have indicated that R-Smads proteins play a pivotal role in mediating crosstalk between receptor serine kinases and receptor tyrosine kinases. However, the molecular mechanisms and the biological implications of R-Smads phosphorylation via receptor serine kinases and receptor tyrosine kinases remain controversial (Kretzschmar et al., 1997 (Kretzschmar et al., , 1999 de Caestecker et al., 1998) .
Without the antibodies (Abs) to selectively distinguish the phosphorylation sites of R-Smads, it has been difficult to determine the phosphorylation sites in intact cells and tissues. Therefore, we developed four types of polyclonal Abs, which specifically recognized the phosphorylated linker regions and the phosphorylated C-terminal SSXS regions in R-Smads (Furukawa et al., 2003; Matsuzaki et al., unpublished data) . Using these phosphorylated domain-specific Abs, we examined whether HGF and TGF-b signals exerted an influence on R-Smads phosphorylation. Thereby, we tried to elucidate if R-Smads could mediate positive responses from both receptor serine kinases and receptor tyrosine kinases. In this paper, we showed that HGF as well as TGF-b could simultaneously stimulate the phosphorylation of endogenous R-Smads at their linker regions. The phosphorylation resulted in an enhanced heterooligomerization of R-Smads with Smad4 and nuclear translocation of the complex. JNK pathway involved HGF and TGF-b-mediated infiltration potency, which was caused partly by plasminogen activator inhibitor type 1 (PAI-1) induced via Smad3 phosphorylation at the linker region. These findings suggest that R-Smads phosphorylation at linker regions plays an important role in transmitting signals from receptor serine kinases and receptor tyrosine kinases.
Results

TGF-b signal simultaneously phosphorylates endogenous R-Smads not only at C-terminal regions but also at linker regions
Considerable amount of evidence supports the hypothesis that serine/threonine phosphorylation of R-Smads is involved in the Smad-mediated signal transduction. R-Smads possess two major phosphorylation sites: the linker region and the C-terminal region (Massague´, 1998) . Phosphorylation of R-Smad takes place on the C-terminal two serine residues within the SSXS motif (Macı´as-Silva et al., 1996) . Accordingly, we generated a polyclonal Ab to the phosphorylated C-terminal region of Smad2 (a pSmad2C [Ser 465/467]) (Matsuzaki et al., unpublished data) , and that to the phosphorylated Cterminal region of Smad3 (a pSmad3C [Ser 423/425]) ( Figure 1a ) (Furukawa et al., 2003) . However, it was difficult to identify precise phoshorylation sites in their linker regions, because the linker regions possess four consensus phosphoacceptor sites for MAPK family members. Each linker region of Smad2 and Smad3 contains one consensus site for ERK (PX(S/T)P) (Davis, 1993; Hill and Treisman, 1995; Kretzschmar et al., 1999) at Thr 219 and at Thr 178 , respectively. ERK-mediated phosphorylation of these sites has been shown to inhibit nuclear translocation of R-Smads and Smad-dependent transcription (Kretzschmar et al., 1997 (Kretzschmar et al., , 1999 . Besides the ERK phosphorylation sites, Smad2 and Smad3 contain a cluster of putative, non-ERK MAPK sites (XX(S/T)P) (Davis, 1993; Hill and Treisman, 1995) , respectively. On the other hand, the JNK pathway has been shown to have positive effects on Smad function (Brown et al., 1999; Engel et al., 1999) . In addition, the linker sequence around Ser 249/254 in Smad2 is different from that around Ser 207/212 in Smad3. Therefore, we prepared phosphospecific polyclonal Abs designated a pSmad2L (Ser 249/254) (Matsuzaki et al., unpublished data) , and a pSmad3L (Ser 207/212) (Furukawa et al., 2003) , which selectively distinguish phosphorylation of Smad2 at the linker region from that of Smad3. Initially, we investigated the time course of R-Smads phosphorylation in response to TGF-b stimulation. The serum-starved RGM-1 cells, which were isolated from normal rat gastric epithelial cells (Kobayashi et al., 1996) , were treated with TGF-b for various time intervals. R-Smads immunopurified with anti-R-Smads Ab were immunoblotted with each anti-phospho-RSmad Ab (Figure 1b) . Before stimulation, the linker sites of R-Smads were slightly phosphorylated under the basal conditions. In contrast, the phosphorylation level was insignificant at the C-terminal regions of R-Smads. TGF-b-dependent-phosphorylation occurred on two serine residues within the linker regions as well as within the C-terminal regions. R-Smads phosphorylation at linker regions and those at the C-terminal regions were detected within 5 min after TGF-b treatment, reached a maximum at 30 min, and decreased thereafter. However, Smad3 phosphorylation at the linker region was persistently observed after 2 h of TGF-b treatment. These results suggest that TGF-b signal simultaneously phosphorylates endogenous R-Smads not only at C-terminal regions but also at linker regions.
HGF signal phosphorylates endogenous R-Smads at linker regions but not at C-terminal regions
We further investigated whether endogenous R-Smads were phosphorylated in response to HGF. In contrast to R-Smads phosphorylation at linker regions as well as C-terminal regions upon TGF-b treatment, HGFdependent phosphorylation occurred on two serine residues within the linker regions but not within the Cterminal regions (Figure 1c ). R-Smads phosphorylation at linker regions was detected within 5 min after HGF treatment, reached a maximum at 30 min, and decreased thereafter. These results suggest that HGF-mediated signal induces selective phosphorylation of endogenous R-Smads at linker regions.
TGF-b and HGF signals additionally phosphorylate the linker regions of R-Smads
We further investigated whether HGF treatment could affect R-Smads phosphorylation in response to TGF-b at 30 min after simultaneous treatment with TGF-b and HGF ( Figure 1d ). Smad2 phosphorylation at the linker region was more sensitive to HGF than to TGF-b, whereas the effect of TGF-b on Smad3 phosphorylation at the linker region was almost equal to that observed with HGF. R-Smads phosphorylation at linker regions was additionally stimulated by both TGF-b and HGF treatment. Taken together, these results suggest that common molecules activated by TGF-b and HGF signals might phosphorylate the linker regions of RSmads. As already mentioned, TGF-b but not HGF treatment strongly enhanced R-Smads phosphorylation at the C-terminal regions. Smad2 phosphorylation at phosphorylates endogenous R-Smads not only at C-terminal regions but also at linker regions. RGM-1 cells were starved for 15 h in serum-free medium, and were incubated with 200 pM TGFb for the indicated times. Following immunoprecipitation (IP) of the cell lysates with anti-Smad2/3 Ab, the phosphorylation levels of R-Smads were analysed by immunoblot (IB) using each antiphospho-R-Smad Ab. The expression of endogenous Smad2 and Smad3 was monitored by immunoblot using anti-Smad2/3 Ab (lower panel). (c) HGF signal phosphorylates endogenous RSmads at linker regions but not at C-terminal regions. RGM-1 cells were starved for 15 h in serum-free medium, and were incubated with 400 pM HGF for the indicated times. Following immunoprecipitation (IP) of the cell lysates with anti-Smad2/3 Ab, the phosphorylation levels of R-Smads were analysed by immunoblot (IB) using each anti-phospho-R-Smad Ab. The expression of endogenous Smad2 and Smad3 was monitored by immunoblot using anti-Smad2/3 Ab (lower panel). (d) TGF-b and HGF signals additionally phosphorylate the linker regions of R-Smads. RGM-1 cells were starved for 15 h in serum-free medium, and were incubated for 30 min with 200 pM TGF-b, 400 pM HGF, or a combination of both. Following immunoprecipitation (IP) of the cell lysates with anti-Smad2/3 Ab, the phosphorylation levels of R-Smads were analysed by immunoblot (IB) using each antiphospho-R-Smad Ab. The expression of endogenous Smad2 and Smad3 was monitored by immunoblot using anti-Smad2/3 Ab (lower panel) the C-terminal region was increased by simultaneous treatment with TGF-b and HGF. In contrast, both TGF-b and HGF treatment did not so much induce Smad3 phosphorylation at the C-terminal region as TGF-b treatment alone.
Collaborative interaction of TGF-b and HGF signals in JNK phosphorylation MAPK pathways were shown to be activated in response to TGF-b and HGF (Robinson and Cobb, 1997; Mulder, 2000) . We next investigated the time course of JNK, p38 MAPK, and ERK activation in response to TGF-b stimulation. RGM-1 cells were starved for 15 h in serum-free medium, and were treated with TGF-b for the indicated times. The activities of MAPKs were monitored by immunoblot using the Abs specific to the phosphorylated JNK, p38 MAPK, and ERK (Figure 2a-c) . JNK and ERK phosphorylation induced by TGF-b treatment was very rapidly; the phosphorylation peaked 5 min after TGF-b treatment, and declined to the basal level by 1 h. However, p38 MAPK phosphorylation was detected after 30 min, reached a maximum at 60 min, and remained elevated during 2 h of TGF-b treatment. Likewise, JNK and ERK phosphorylation induced by HGF treatment was very rapid (Figure 2d-f) . In contrast to the delayed response to TGF-b, HGF rapidly activated p38 MAPK. The phosphorylation was detected within 5 min upon HGF treatment, reached a maximum within the first 15 min, and gradually declined thereafter. We next investigated whether HGF treatment could affect JNK phosphorylation in response to TGF-b (Figure 2g Collectively, these data indicate that both Smad2 and Smad3 serve as the substrates for JNK in vitro after TGF-b and HGF treatment. In comparison with JNK, p38 MAPK activated at 15 min after HGF treatment failed to phosphorylate Smad2 at the linker region, but it could phosphorylate Smad3 at the linker region (data not shown). As a control, ERK activated by TGF-b signal could not phosphorylate Smad2 and Smad3 at these sites; moreover, a MEK1 inhibitor PD98059 treatment had no effect on the phosphorylation (data not shown).
Both JNK and p38 MAPK involve Smad3 phosphorylation at the linker region
To confirm the involvement of JNK and p38 MAPK in R-Smads phosphorylation in vivo, RGM-1 cells were preincubated with a JNK inhibitor SP600125 or a p38 MAPK inhibitor PD169316, and then the cells were stimulated with TGF-b and/or HGF for 30 min. SP600125 selectively inhibited TGF-b or HGF-mediated R-Smads phosphorylation at linker regions, but failed to inhibit the phosphorylation at C-terminal regions (Figures 1d and 4a ). When R-Smads phosphorylation at linker regions was inhibited by SP600125, HGF treatment did not affect R-Smads phosphorylation at C-terminal regions regulated by TGF-b. In contrast, PD169316 partially inhibited not TGF-b but HGF-dependent Smad3 phosphorylation at the linker region (Figures 1d and 4b ). When HGF-dependent Smad3 phosphorylation at the linker region was inhibited by PD169316, HGF treatment could not so much reduce Smad3 phosphorylation at the C-terminal region stimulated by TGF-b. Neither TGF-b nor HGF-mediated Smad2 phosphorylation at the linker region was inhibited by PD169316. These results were consistent with the findings that both Smad2 and Smad3 could serve as the substrates for JNK in vitro following TGF-b treatment (Figure 3 ), whereas the activated p38 MAPK could directly phosphorylate not Smad2 but Smad3 at the linker region in vitro (data not shown). In contrast to rapid response to HGF, p38 MAPK phosphorylation induced by TGF-b treatment was slow and persistent; p38 MAPK phosphorylation reached a maximum at 60 min, and remained elevated during 2 h of TGF-b treatment (Figure 2b , e). Collectively, Smad3 phosphorylation at the linker region at 30 min after TGF-b treatment could be mainly caused by the activated JNK, whereas p38 MAPK might persistently phosphorylate Smad3 at the linker region in RGM-1 cells (Figure 1b ).
JNK-dependent R-Smads phosphorylation at linker regions induced by either TGF-b or HGF treatment allows R-Smads to associate with Smad4
R-Smads/Smad4 complexes translocate into the nucleus, where they activate the TGF-b-responsive genes. Accordingly, we investigated whether HGF signal had an effect on the complex formation. After RGM-1 cells were treated with TGF-b and/or HGF, the cell lysates were immunoprecipitated with each anti-phospho-R-Smad Ab, and Smad4 in the immunoprecipitate was detected by immunoblot using antiSmad4 Ab. As shown in Figure 5a , interactions between the phosphorylated R-Smads and Smad4 were scarcely present in the unstimulated culture. TGF-b treatment induced the complex formation of the phosphorylated R-Smads with Smad4. Similarly, treatment of the cells with HGF induced the complex formation between RSmads phosphorylated at linker regions and Smad4. However, increase in the associations between R-Smads phosphorylated at the C-terminal regions and Smad4 was not observed in the cells treated with HGF. These results, coupled with the findings shown in Figures 1c  and 3 , suggest that HGF-mediated association of RSmads with Smad4 is JNK-dependent. Additional treatment of HGF with TGF-b led to an increase in the association between Smad2 phosphorylated at the linker region and Smad4. Similarly, both TGF-b and HGF treatment increased the association between Smad2 phosphorylated at the C-terminal region and Smad4. These data indicate that TGF-b and HGF additionally induce the complex formation of Smad2 with Smad4 through Smad2 phosphorylation both at the linker region and at the C-terminal region. In contrast, additional treatment of HGF with TGF-b did not so much stimulate the associations between the phosphorylated Smad3 and Smad4 as TGF-b treatment alone. Difficulty of these associations between Smad3 and Smad4 might be due to higher affinity of Smad4 to the phosphorylated Smad2 than those to Smad3.
We further investigated effects of SP600125 on the complex formation of phosphorylated R-Smads with Smad4 ( Figure 5b ). RGM-1 cells were preincubated with SP600125, and then were stimulated with TGF-b and/or HGF. SP600125 selectively inhibited TGF-b or HGF-mediated complex formation between R-Smads phosphorylated at linker regions and Smad4, but failed to inhibit the complex formation between R-Smads phosphorylated at C-terminal regions and Smad4. When RSmads phosphorylation at linker regions was inhibited by SP600125, HGF treatment did not affect TGF-bmediated complex formation between R-Smads phosphorylated at C-terminal regions and Smad4.
Consistent with the observation that HGF-mediated signal induces phosphorylation of endogenous R-Smads at linker regions but not at C-terminal regions (Figure 1c ), HGF-dependent R-Smads phosphorylation at linker regions was observed in R-Smads(3S-A) lacking C-terminal serine residues, but not in R-Smads EPSM lacking phosphorylation sites in the linker regions (data not shown). We therefore decided to investigate whether HGF-dependent signaling occurred at the downstream steps in these R-Smads mutants. RGM-1 cells were transfected with Smad4-HA in the presence of Flag-Smad2WT, Smad2EPSM, or Smad2(3S-A). The cell lysates were immunoprecipitated with anti-Flag Ab, and Smad4 in the immunoprecipitate was detected by immunoblot using anti-HA Ab. As shown in Figure 5c , marginal interaction between Smad2 and Smad4 was observed in the unstimulated culture. A significant increase in the association of Smad2WT with Smad4 was observed in the cells after HGF treatment. HGF treatment induced relatively weak interactions between Smad2(3S-A) and Smad4, as compared with HGF-dependent interaction of Smad2WT with Smad4. However, HGF treatment failed to increase the interaction of Smad2EPSM with Smad4. The ligand-dependent interaction of the activated Smad3 with Smad4 was observed similarly in Smad3(3S-A) but not in Smad3EPSM (Figure 5d ). These results, coupled with the findings shown in Figure 1c , suggest that HGF treatment induces the association of R-Smads with Smad4 through the linker phosphorylation, but not through the C-terminal phosphorylation.
Simultaneous treatment with HGF and TGF-b leads to stimulate nuclear translocation of R-Smads phosphorylated at linker regions Translocation of R-Smads into the nucleus upon receptor-mediated phosphorylation is a central event in TGF-b signal transduction (Macı´as-Silva et al., 1996) . To gain additional insight into the significance of R-Smads phosphorylation, we examined intracellular localization of the phospho-R-Smads. To this end, we treated RGM-1 cells with TGF-b and/or HGF, and observed intracellular localization by indirect immunofluorescence microscopy using each anti-phospho-RSmad Ab (Figure 6a ). R-Smads were scarcely phosphorylated in the absence of exogenous TGF-b. In all, 85% Smad2 phosphorylated at the linker region was located in cytoplasm upon TGF-b or HGF treatment, whereas additional treatment of HGF with TGF-b Figure 2 Collaborative interaction of TGF-b and HGF signals in JNK phosphorylation. RGM-1 cells were starved for 15 h in serumfree medium, and were incubated with 200 pM TGF-b (a, b, c) or 400 pM HGF (d, e, f) for the indicated times. The phosphorylation levels of endogenous MAPKs were analysed by immunoblot (IB) using anti-phospho-JNK1/2 Ab (a pJNK1/2) (a, d), anti-phosphop38 MAPK Ab (a pp38) (b, e), and anti-phospho-ERK1/2 Ab (a pERK1/2) (c, f). The total amount of each MAPK did not change during stimulation (lower panel). (g) TGF-b and HGF signals additionally stimulate JNK phosphorylation. Serum-starved RGM-1 cells were incubated for 15 min with 200 pM TGF-b, 400 pM HGF, or a combination of both. The phosphorylation levels of endogenous JNK1/2 were determined by immunoblot using anti-phospho-JNK1/2 Ab (a pJNK1/2) (upper panel). The expression of endogenous JNK1/2 was monitored by immunoblot using anti-JNK1/2 Ab (a JNK1/2) (lower panel). Bottom: Graphical analyses of immunoblots showing the ratio of phospho-JNK1/2 to total JNK1/2 (a, d, g), phospho-p38 to total p38 (b, e) or phospho-ERK1/2 to total ERK1/2 (c, f) after stimulation with TGF-b and/or HGF. Intensities of phospho-JNK1/2, p38 or ERK1/2 bands were normalized to those of total JNK1/2, p38 or ERK1/2 of the corresponding treatment groups. The ratio of the phosphorylated protein to total protein without exogenous TGF-b or HGF is assigned a value of 1
Crosstalk of TGF-b and HGF signals S Mori et al translocated the phosphorylated Smad2 into the nuclei. Taken together with the results of a report that forced expression of a constitutively active form of mitogenactivated protein kinase kinase kinase-1 (MEKK-1), which is an upstream activator of the JNK pathway, stimulates nuclear localization of Smad2 (Brown et al., 1999) , these results indicate that Smad2 phosphorylated at the linker region sets a high threshold for nuclear translocation. Otherwise, Smad2 phosphorylated at the linker region might remain in the cytoplasm as far as TbRI-mediated Smad2 phosphorylation does not occur at the C-terminal site. In contrast, either TGF-b or HGF treatment alone led to nuclear translocation of Smad3 phosphorylated at the linker region, and both treatment additionally stimulated this nuclear translocation. Likewise, Smad3 phosphorylation by JNK facilitates its nuclear accumulation (Engel et al., 1999) . These results indicate that Smad3 phosphorylated at the linker region has a lower threshold for nuclear translocation than does the phosphorylated Smad2. As expected, most Smad2 phosphorylated at the C-terminal region was located in the nuclei upon TGF-b treatment.
In contrast, exposure to excess HGF did not lead to nuclear accumulation of the phosphorylated Smad2. Similarly, nuclear accumulation of Smad3 phosphorylated at the C-terminal region was stimulated by TGF-b treatment, but not by HGF treatment. Consistent with the reduced Smad3 phosphorylation at the C-terminal region (Figure 1d ), additional treatment of HGF with TGF-b did not so much induce the nuclear accumulation of the phosphorylated Smad3 as TGF-b treatment alone. These results could be explained by inaccessibility of Smad3 to TbRI as a result of JNK-dependent nuclear localization of Smad3. We further investigated the effects of SP600125 on intracellular localization of phosphorylated R-Smads (Figure 6b ). RGM-1 cells were preincubated with SP600125, and then were stimulated with TGF-b and/ or HGF. SP600125 selectively inhibited TGF-b or HGF-mediated intracellular localization of R-Smads phosphorylated at linker regions, but failed to inhibit nuclear localization of R-Smads phosphorylated at C-terminal regions.
SP600125 treatment causes the reduction of invasive capacity induced by TGF-b and HGF signals
Both HGF and TGF-b are proposed as main participants in the promotion of tumor cell invasion and metastasis (Stoker et al., 1987; Wakefield and Roberts, 2002) . We therefore investigated whether HGF and TGF-b enhanced infiltration potency of RGM-1 cells, Figure 5 JNK-dependent R-Smads phosphorylation at linker regions induced by either TGF-b or HGF treatment allows RSmads to associate with Smad4. Serum-starved RGM-1 cells were incubated for 8 h in the absence (a) or presence (b) of 10mM SP600125, and were then treated for 40 min with 200 pM TGF-b, 400 pM HGF, or a combination of both. Cell lysates were subjected to immunoprecipitation (IP) with each anti-phospho-R-Smad Ab or anti-R-Smads Ab, and Smad4 in the immunoprecipitate was detected by immunoblot (IB) using anti-Smad4 Ab. Total Smad4 and Smad2/3 were monitored by immunoblot (IB) using antiSmad4 Ab and anti-Smad2/3 Ab, respectively (lower panels). (c) HGF treatment induces the complex formation of Smad2(3S-A) with Smad4. RGM-1 cells were transfected with Smad4-HA in the presence of Flag-Smad2WT, Smad2EPSM, or Smad2(3S-A), and were treated with HGF. The cell lysates were then subjected to immunoprecipitation (IP) with anti-Flag Ab, and Smad4 in the immunoprecipitate was detected by immunoblot (IB) using anti-HA Ab. The expression of Flag-Smad2 and Smad4-HA was monitored by immunoblot (IB) using anti-Flag Ab and anti-HA Ab, respectively. (d) HGF treatment induces the complex formation of Smad3(3S-A) with Smad4. RGM-1 cells were transfected with Smad4-HA in the presence of Flag-Smad3WT, Smad3EPSM, or Smad3(3S-A), and were treated with HGF. The cell lysates were then subjected to immunoprecipitation (IP) with anti-Flag Ab, and Smad4 in the immunoprecipitate was detected by immunoblot (IB) using anti-HA Ab. The expression of Flag-Smad3 and Smad4-HA was monitored by immunoblot (IB) using anti-Flag Ab and anti-HA Ab, respectively 
TGF-b and HGF signals stimulate PAI-1 transcription through Smad3 phosphorylation at the linker region
The processes of cellular invasion are characterized, in part, by altered local proteolysis and stimulating cell growth. Plasminogen activator inhibitor type 1 (PAI-1), the main inhibitor of the urokinase-type plasminogen activator system, conducts the cells to migration and invasion by blocking cellular adhesion and by promoting basement membrane degradation (Gutierrez et al., 2000) . Moreover, PAI-1-induced TGF-b signal stimulates attachment and invasion in primary ovarian cancer cells (Hirashima et al., 2003) . Therefore, we investigated whether HGF and TGF-b regulated PAI-1 expression in RGM-1 cells. Northern blot analyses of PAI-1 on RNA prepared from RGM-1 cells revealed that PAI-1 mRNA (3.2 kb) were rapidly induced either by TGF-b or HGF (Figure 8a ). Additional treatment of HGF with TGF-b enhanced PAI-1 upregulation at the mRNA level, when compared with those upon HGF or TGF-b treatment alone.
To investigate the role of JNK in the regulation of TGF-b and HGF signaling, we next examined effects of dominant-negative form of MEKK-1 on the activities of PAI-1 promoter. For the assays, we used PF1-Luc, because the segment in human PAI-1 promoter was sufficient to obtain TGF-b-dependent induction (Hua et al., 1998) . RGM-1 cells transfected PF1-Luc alone showed a low level of transcriptional activity (Figure 8b ). TGF-b strongly induced the transcriptional activity, and HGF treatment led to an increase in the transcriptional We further investigated effects of Smad3 phosphorylation on another transcriptional activity. For the assays, we used (SBE) 4 -Luc, because TGF-b-induced activation of (SBE) 4 -Luc, driven by four repeats of the CAGACA sequence identified as Smad binding element in the JunB promoter (Jonk et al., 1998) , was dependent on expression of Smad3, but not on expression of Smad2 (Piek et al., 2001) . Treatment with either TGF-b or HGF induced an increase in (SBE) 4 -luciferase reporter activation (Figure 8d) . Moreover, additional treatment of HGF with TGF-b led to an increase in the transcriptional activity. HGF treatment of the cells expressing either Smad3WT or Smad3(3S-A) led to increase in the activity. However, cotransfection with Smad3EPSM could not lead to an activation of the (SBE) 4 -luciferase reporter in RGM-1 cells treated with HGF. Collectively, HGF signaling pathway alone increases transcriptional activities of PF1-Luc and (SBE) 4 -Luc in RGM-1 cells. In addition, it enhances TGF-b signal through Smad3 phosphorylation at the linker region.
Activation of p15 INK4B promoter requires not linker but C-terminal phosphorylation of Smad3
In most epithelial cells, signaling mediated by receptor tyrosine kinases antagonized the antiproliferative effect of TGF-b (Roberts et al., 1985) . In this respect, we also observed that the antiproliferative effect of TGF-b on RGM-1 cells was partially blocked by HGF cotreatment (data not shown). TGF-b-induced growth arrest is attributed in part to the induction of a tumor suppressor gene, p15 INK4B (Hannon and Beach, 1994) . Accordingly, we examined which phosphorylation of Smad3 involved the activity of p15 INK4B promoter, linker or C-terminal region. For the assays, we used p15P113-luc, because the segment in human p15
INK4B promoter was sufficient to obtain TGF-b-dependent induction (Li et al, 1995) . Cotransfection of p15P113-luc with Smad3WT or Smad3EPSM in RGM-1 cells caused to increase the basal transcriptional activity, when compared with that in cells transfected with p15P113-luc alone (Figure 9 ). TGF-b treatment activated the transcription, but HGF treatment suppressed the transcriptional activity triggered by TGF-b treatment. Since Smad3EPSM revealed TGF-b-dependent phosphorylation at the C-terminal region (Furukawa et al., 2003) , these results indicate that activation of p15 INK4B promoter requires not linker but C-terminal phosphorylation of Smad3. Therefore, a possible mechanism for HGF suppression of the transcriptional activity is via inhibition of Smad3 phosphorylation at the C-terminal region by HGF cotreatment (Figure 1d ). To support this notion, forced expression of Smad3(3S-A), in which the linker region was exclusively phosphorylated, exhibited suppressive effects on the transcription.
Discussion
We herein described the crosstalk between receptor serine kinase and receptor tyrosine kinase signaling pathways as important implications in R-Smadsmediated signaling. Since phospho-specific Abs allow site-specific analyses in intact cells, we could focus on the domain-specific phosphorylated states of R-Smads under physiological conditions. HGF as well as TGF-b treatment activated the JNK pathway, thereafter inducing endogenous R-Smads phosphorylation at linker regions, whereas the phosphorylation at their C-terminal regions was not induced by HGF treatment. The activated JNK could directly phosphorylate R-Smads in vitro at the same sites that were phosphorylated in response to TGF-b or HGF in vivo. Thus, the linker regions of R-Smads are the common phosphorylation sites for HGF and TGF-b signaling pathways.
Nuclear translocation of Smad3 phosphorylated at the linker region by HGF stimulation strongly indicated the biological significance of the linker phosphorylation. In fact, HGF alone stimulated the invasiveness of RGM-1 cells as observed with TGF-b-stimulation, and costimulation with these two factors resulted in the additive invasive effect (Figure 7 ). Since JNK inhibitor suppressed these biological effects, JNK pathway could involve TGF-b and HGF-mediated infiltration potency of RGM-1 cells. In addition, our current data demonstrated that HGF treatment alone induced an activation of PAI-1 transcription, which was prominent under conditions of Smad3WT overexpression. More importantly, a combined treatment with HGF and TGF-b strongly activated PAI-1 promoter. This additional effect was dependent on Smad3 phosphorylation at the linker region by JNK pathway, because it was prevented by dominant-negative form of MEKK-1 and by transfection of Smad3EPSM. Since PAI-1 conducts the cells to migration and invasion by blocking cellular Figure 9 Activation of p15 INK4B promoter requires not linker but C-terminal phosphorylation of Smad3. RGM-1 cells were transiently cotransfected of p15P113-luc with Smad3WT, Smad3EPSM, or Smad3(3S-A). Under serum-free conditions, the cells were incubated for 12 h with 200 pM TGF-b, 400 pM HGF, or a combination of both. Luciferase activities were determined above adhesion and by promoting basement membrane degradation, stimulation of PAI-1 production might lead to an increase in invasive capacity of RGM-1 cells. Therefore, we conclude that the linker phosphorylation can participate in invasive capacity of RGM-1 cells.
The crosstalk between Smads and MAPK-mediated signals has been reported to occur in the nucleus (Wrana, 2000b) . Several TGF-b-responsive elements in target genes including PAI-1 gene contain AP1 sites. Smad3-Smad4 heteromers can form DNA binding complexes with Jun-Fos heterodimers on AP1 sites . Another transcription factor ATF2, which is a member of the b-ZIP family of DNA binding proteins, binds to the MH1 domains of Smad3 or Smad4, and these Smads cooperate with ATF2 to activate the reporter containing cAMP response elements (Sano et al., 1999) . Importantly, TGF-b can activate MAPKs, which in turn regulate the activity of Jun, Fos and ATF-2 and related transcription factors (Zhang and Derynck, 1999) . In the nucleus, therefore, Smads interact with these proteins that are themselves targeted by MAPKs. On the other hand, our current results imply that the crosstalk already occurs at the cytoplasmic level. In the cytoplasm, JNK directly phosphorylates R-Smads, leading to the transcriptional activation of PAI-1 gene in the nucleus.
On the other hand, receptor tyrosine kinase signaling pathway interferes with Smads to regulate TGF-bresponsive genes, resulting in antagonistic effects (Roberts et al., 1985) . In fact, antiproliferative effect of TGF-b was partially inhibited by HGF cotreatment to RGM-1 cells. The decreased sensitivity of RGM-1 cells to the antiproliferative effect of TGF-b could be caused partly by reduced expression of the cell cycle regulator p15
INK4B
, because HGF decreased transcriptional activity of p15 INK4B induced by TGF-b (Figure 9 ). In addition, the induction of p15 INK4B transcription required not linker but C-terminal phosphorylation of Smad3. Therefore, inhibitory effects of HGF on TGF-binduced p15 INK4B transcription could be associated with decreased phosphorylation of Smad3 at the C-terminal region by HGF cotreatment (Figure 1d ). Since HGFmediated Smad3 phosphorylation at the linker region alone promoted nuclear accumulation of Smad3, the reduction of Smad3 phosphorylation at the C-terminal region could be explained by inaccessibility of Smad3 to TbRI as a result of the preferential localization of Smad3 into the nucleus. Future work will examine whether Smad3 phosphorylated at linker region and that phosphorylated at C-terminal region differentially interact with the DNA binding partners, or recruit the transcriptional coactivators on PAI-1 and p15
promoters.
Our present study has brought important insights into the diversity and complexity of TGF-b-mediated signal transduction. Such an arrangement may also have implications as regards the effects of TGF-b on tumor formation and progression (Wakefield and Roberts, 2002) . TGF-b can act as either a tumor suppressor or a tumor promoter, depending upon the cellular context. In tumor cells that have become refractory to TGF-bmediated growth inhibition, R-Smads phosphorylation at linker regions, in cooperation with JNK pathway, could influence tumor behavior. Consistent with the phosphorylated states of R-Smads upon HGF treatment, Smad3 highly phosphorylated at the linker region was located in the nuclei of human gastric cancerous tissues, whereas Smad2 phosphorylated at the linker region was located predominantly in the cytoplasm of the cancer cells (data not shown). In the future, identification of the phosphorylation sites in R-Smads using the specific Abs to the phosphorylated domains will reveal the molecular basis for TGF-b signaling alterations that promote the pathogenesis of human cancer.
Materials and methods
Cell culture
A rat cell line (RGM-1) was established from normal gastric mucosa (Kobayashi et al., 1996) . The cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum and antibiotics.
Northern blot hybridization analysis RGM-1 cells were starved for 15 h in serum-free medium, and were treated with 200 pM TGF-b 1 (R&D Systems, Minneapolis, MN, USA) and/or 400 pM HGF (R&D Systems) for 3 h. mRNAs were isolated and hybridized with labeled cDNAs probes for PAI-1 and GAPDH as described (Matsuzaki et al., 2000) . Total RNA was isolated from cultured cells by extraction in guanidinium isothiocyanate/phenol/chloroform, and poly(A)-rich RNA was selected using oligo(dT)-cellulose (New England Biolabs Inc., Beverly, MA, USA). Aliquots (2 mg) of poly(A)-rich RNA were denatured with 2.2 M formaldehyde/50% formamide, electrophoresed through 1% agarose gels containing 2.2 M formaldehyde, and transferred onto nylon membranes (Amersham International, Buckinghamshire, UK). cDNAs were labeled with [ 32 P]dCTP (3000 Ci/ mmol; Amersham International) by the random primer labeling method. The filters were hybridized with the cDNA probe in solution containing 50% formamide.
Constructs and reagents
Mammalian expression vector with an N-terminal Flag tag was constructed by inserting oligonucleotides encoding epitope-tag sequences into pcDNA3 (Invitrogen, Carlsbad, CA, USA). The coding region of Smad3 was amplified by PCR and subcloned into Flag-pcDNA3. Smad3EPSM was produced by PCR-based mutagenesis as described (Kretzschmar et al., 1999) . PF1-Luc (Hua et al., 1998) was constructed by inserting the DNA fragment corresponding to À794/À532 of the PAI-1 promoter into pGL3-basic vector (Promega, Madison, WI, USA). The integrity of the constructs was confirmed by sequencing. Dominant-negative form of MEKK-1, (SBE) 4 -luciferase reporter plasmid and p15P113-luciferase reporter plasmid were gifts from Dr S Ohno, Dr P ten Dijke, Dr X-F Wang, respectively.
Immunoprecipitation and immunoblot
To investigate effects of TGF-b and/or HGF on the phosphorylation of endogenous R-Smads, RGM-1 cells were starved for 15 h in serum-free medium, and were incubated for 8 h in the absence or presence of 10 mM JNK inhibitor SP600125 (Calbiochem, San Diego, CA, USA) or 10 mM p38 MAPK inhibitor PD169316 (Calbiochem). The cells were then treated with 200 pM TGF-b 1 and/or 400 pM HGF for the indicated times. Following adsorption to protein-G-Sepharose (Amersham Biosciences, Piscataway, NJ, USA) with antiSmad2/3 Ab (BD Bioscience, San Jose, CA, USA), the phosphorylation levels of R-Smads were monitored by immunoblot using each domain-specific Ab against the phosphorylated R-Smads (a pSmad2L [Ser 249/254] (Furukawa et al., 2003; Matsuzaki et al., unpublished data) . To investigate heteromeric complex formation of endogenous R-Smads with endogenous Smad4, the cells were incubated for 8 h in the absence or presence of 10 mM JNK inhibitor SP600125, and were treated with 200 pM TGF-b 1 and/or 400 pM HGF for 40 min. The cell lysates were subjected to immunoprecipitation with each anti-phospho-R-Smad Ab or anti-R-Smads Ab, and Smad4 in the immunoprecipitate was monitored by immunoblot using mouse monoclonal antiSmad4 Ab (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Other immunoblots were performed using the following primary Abs: rabbit polyclonal anti-phospho-JNK1/2 Ab (Promega), rabbit polyclonal anti-phospho-p38 MAPK Ab (Promega), rabbit polyclonal anti-phospho-ERK 1/2 Ab (Promega), rabbit polyclonal anti-JNK1/2 Ab (Cell Signaling, Beverly, MA, USA), rabbit polyclonal anti-ERK1/2 Ab (Cell Signaling), and rabbit polyclonal anti-p38 Ab (Calbiochem). Samples were subjected to SDS-PAGE and then were transferred to nitrocellulose membranes (Amersham Biosciences). The blots were incubated with primary Ab for 2 h at room temperature, and then were washed three times. The appropriate secondary Ab was added for 1 h at room temperature. After washing, the immunoreactive proteins were visualized by ECL (Amersham Biosciences) and autoradiography.
In vitro kinase assays
Smad constructs were subcloned into pGEX-4T-1 expression vector (Amersham Biosciences) encoding an amino-terminal GST tag. Bacterial expression and purification of GST-Smad2 and GST-Smad3 were carried out according to the manufacturer's instructions (Amersham Biosciences). RGM-1 cells were starved for 15 h in serum-free medium, and were incubated with 200 pM TGF-b 1 and/or 400 pM HGF for 15 min. Endogenous kinases were isolated from the cell extracts using anti-phospho-JNK Ab (Promega). Immune complexes were collected with protein G-Sepharose and were washed four times with lysis buffer and then twice with kinase assay buffer (25 mM Tris-HCl (pH 7.5), 5 mM b-glycerophosphate, 2 mM DTT, 0.1 mM Na 3 VO 4 , and 10 mM MgCl 2 ). Pellets were resuspended in 50 ml of kinase assay buffer supplemented with 100 mM ATP; and 2 mg of bacterially expressed GST-Smad2 or GST-Smad3. Assays were carried out at 301C for 30 min and then were stopped with Laemmli sample buffer. Phosphorylation sites of R-Smads were determined by immunoblot using each anti-phospho-RSmad Ab.
Immunofluorescence study
The subcellular localization of Smads was determined as previously described (Matsuzaki et al., 2000) . The cells were starved for 15 h in serum-free medium, and were incubated for 8 h in the absence or presence of 10 mM JNK inhibitor SP600125. The cells were then treated with 200 pM TGF-b 1 and/or 400 pM HGF for 1 h. After fixation with 4% paraformaldehyde, the slides were incubated with a primary Ab at 41C for 16 h. Endogenous Smad proteins were visualized with each anti-phospho-R-Smad Ab. In all cases, at least 100 stained cells were counted. Anti-pSmad3C Ab weakly crossreacted with the C-terminally phosphorylated Smad2. To block the binding of anti-pSmad3C Ab to the phosphorylated domains in Smad2, anti-pSmad3C Ab was adsorbed with 1 mg/ml C-terminally phosphorylated Smad2 peptide.
Invasion assay
An invasion chamber with 8-mm membrane pores covered with Matrigel (BD Biosciences) was placed on a cell culture plate. RGM-1 cells (2 Â 10 4 ) were cultured on Matrigel for 48 h with 200 pM TGF-b 1 and/or 400 pM HGF in the absence or presence of 10 mM JNK inhibitor SP600125. The chambers were then immersed in 100% methanol for 1 min for fixation, and all cells were then stained by hematoxylin. The cells remaining on the top surface of the membrane were completely removed with a cotton swab, and the membrane was removed from the chamber and mounted on a glass slide. These preparations were examined under a microscope at Â 100 magnification. The number of infiltrating cells was counted in five regions selected at random, and the extent of invading cells was determined by the mean count. Duplicate filters were used, and the experiments were repeated three times.
Transcriptional response assay
The cells were subjected to transfection with LipofectAMINE (Invitrogen), 0.4 mg of reporter plasmid, and the indicated constructs or with an empty vector, and were incubated for 4 h. After changing the medium, the cells were incubated for a further 30 h. Under serum-free conditions, the cells were incubated for 12 h with 200 pM TGF-b 1 and/or 400 pM HGF. Finally, they were lysed, and the luciferase activities of the cell extracts were measured by a luminometer (Berthold, Bad Wildbad, Germany) using Dual-Luciferaset Reporter Assay System (Promega). The luciferase activities were normalized based on the Renilla luciferase activity.
Abbreviations ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MEKK-1, mitogen-activated protein kinase kinase kinase-1; PAI-1, plasminogen activator inhibitor type 1; R-Smads, receptor-regulated Smads; SAPK, stress-activated protein kinase; TAK1, TGF-b-activated kinase 1; TbRI, TGF-b type I receptor.
